Thermo Fisher Scientific Inc. (NYSE:TMO) has established itself as one of the best stocks that will always grow, according to a recent report. The company recently announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center in South San Francisco. This center aims to provide biotechnology and pharmaceutical innovators with access to advanced cryo-EM technologies that can expedite structural insights and the development of life-saving therapies.
The management at Thermo Fisher Scientific Inc. highlighted that the new center offers direct access to advanced cryo-EM innovation and scientific expertise, which can significantly reduce barriers to adoption. Cryo-EM technology can be utilized to expand the range of therapeutic targets and advanced therapies for structure-based methods. It also enables pharmaceutical companies to bring drugs to clinics faster. The company stated that structure-guided drugs have a higher rate of clinical success in less time and at a lower cost compared to industry standards.
Glyn Davies, the president of Materials & Structural Analysis at Thermo Fisher Scientific Inc., emphasized that the opening of the Cryo-EM Drug Discovery Center fosters a collaborative environment where scientists can leverage the power of Cryo-EM to better understand disease at the molecular level and accelerate therapeutic development.
Thermo Fisher Scientific Inc. is known for providing analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. The company operates through various segments, including Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics.
While Thermo Fisher Scientific Inc. shows promise as an investment, some AI stocks may offer greater upside potential with less downside risk. Investors looking for undervalued AI stocks that could benefit from current market trends may want to explore other options. For more information on potential investment opportunities, readers are encouraged to check out our free report on the best short-term AI stock.
In conclusion, Thermo Fisher Scientific Inc.’s new Cryo-Electron Microscopy Drug Discovery Center represents a significant step forward in advancing structural insights and therapeutic development. The company’s commitment to innovation and collaboration underscores its position as a leader in the field of life sciences.
